NOTES
TO FINANCIAL STATEMENTS
As
of August 31, 2019 and 2018
1.
NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN
Nature
of Business Operations
Bespoke Extracts, Inc. (the “Company”)
is a Nevada corporation focused on marketing and selling a proprietary line of premium, quality, all natural CBD products in the
forms of tinctures, capsules, drops and edibles for the nutraceutical and veterinary markets, which it introduced in mid-2018.
Produced using pure, all natural, zero-THC phytocannabinoid-rich (“PCR”) hemp-derived isolate, the Company markets
its products as dietary supplements through its retail ecommerce store found at www.bespokeextracts.com. In the future, the
Company also intends to sell its products through wholesale channels.
Going
Concern
The
accompanying financial statements have been prepared assuming a continuation of the Company as a going concern. The
Company had negative cash flows from operations, a working capital deficit and an accumulated deficit for the year ended and
as of August 31, 2019. This raises substantial doubt about our ability to continue as a going concern.
The
Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future
and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations
when they come due. There is no assurance that this series of events will be satisfactorily completed. The accompanying financial
statements do not contain any adjustments that may result from the outcome of this uncertainty.
Use
of Estimates
The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires
management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying
notes. Actual results could differ from those estimates.
Cash
and Cash Equivalents
Cash
and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase.
At August 31, 2019 and 2018, the Company did not have any cash equivalents.
Fair
Value of Financial Instruments
The
carrying amounts of cash, accounts receivable, prepaid expenses and other assets, accounts payable, accrued liabilities and notes
payable to stockholder approximate their fair values as of August 31, 2019 and 2018, respectively, because of their short-term
natures.
Accounts
Receivable
Accounts
receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts
for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the
Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required.
The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical
collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may
not meet expectations and may result in decreased cash flows and increased bad debt expense.
The
policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30
or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging
off uncollectible receivables is made.
Inventory
Inventories
are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net
realizable value. Net realizable value is defined as sales price less cost of completion, disposable and transportation and a
normal profit margin. As of August 31, 2019 and August 31, 2018, inventory amounted to $3,171 and $61,857, respectively, which
consisted of finished goods. During the year ended August 31, 2019 the Company reserved $52,332 for slow moving inventory.
Revenue
Recognition
Net
revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits
and returns (calculated based upon previous experience and management’s evaluation). Outbound shipping charged to customers
is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound
shipping and delivery costs are included in cost of revenues. Net revenues exclude sales and other similar taxes collected from
customers.
Our products sold through our online and telephonic
channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment.
Payment is typically due on the date of shipment. The Company offers a 14 day return policy on sales.
The
Company accounts for revenue in accordance with Topic 606 which was adopted at the beginning of fiscal year 2018 using the modified
retrospective method. The comparative information has not been restated and continues to be reported under the accounting standards
in effect for those periods. The Company did not recognize any cumulative-effect adjustment to retained earnings upon adoption
as the effect was immaterial. The adoption of these standards did not have a material impact on the Company’s statements of operations
during the year ended August 31, 2018.
Stock
Option Plans
Stock
options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted
for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is
more reliably measurable in accordance with, and FASB ASC 718, Compensation-Stock Compensation, including related
amendments and interpretations. The related expense is recognized over the period the services are provided. Stock option compensation
expense has been recognized as a component general and administrative expenses in the accompanying financial statements for the
years ended August 31, 2019 and 2018.
Net
Income / Loss per Share
Basic
income / loss per share amounts are computed based on net income / loss divided by the weighted average number of common shares
outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were
exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application
of the treasury stock method and the effect of convertible securities by the “if converted” method. Outstanding options,
warrants and convertible debt were excluded from the calculation of diluted income / loss per share during the years ended August
31, 2019 an August 31, 2018 because their inclusion would have been anti-dilutive. The effect of 3,330,000 warrants and 1,200,000
options is anti-dilutive for the year ended August 31, 2019. The effect of 2,830,000 warrants and 1,200,000 options is anti-dilutive
for the year ended August 31, 2018.
Recent
Accounting Pronouncements
In
February 2016, the FASB issued ASU 2016-02, Leases, which will amend current lease accounting to require lessees to recognize
(i) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted
basis, and (ii) a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of,
a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors;
however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model. This standard
was effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years.
The
adoption of ASU 2016-02 is not expected to have a significant impact on our balance sheet, results of operations or balance sheets
as we currently do not have any long term corporate office and equipment leases.
2.
ASSET PURCHASE AGREEMENT
On
February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain domain names
set forth in an asset purchase agreement for a total of $20,185 in cash and 200,000 shares of the Company’s common stock
valued at $30,000. For the years ended August 31, 2019 and August 31, 2018 amortization expense amounted to $3,345 and $3,346
respectively. The domain names are being amortized over a 15 year period.
3.
NOTE PAYABLE – RELATED PARTY
The
changes in a note payable to a related party consisted of the following during the years ended August 31, 2019 and August 31,
2018.
|
|
August 31,
2019
|
|
|
August 31,
2018
|
|
Notes payable – related party at beginning of period
|
|
$
|
50
|
|
|
$
|
50
|
|
Payments on notes payable – related party
|
|
|
-
|
|
|
|
-
|
|
Borrowings on notes payable – related party
|
|
|
-
|
|
|
|
-
|
|
Note payable – related party at end of period
|
|
$
|
50
|
|
|
$
|
50
|
|
On
February 14, 2017, the Company issued to Lyle Hauser, the Company’s largest shareholder at the time, a 7% unsecured promissory
note in the amount of $30,000 which matured six months from the date of issuance. On May 31, 2018 the Company repaid the promissory
note in the amount of $30,000 and accrued interest of $2,811.
On
May 17, 2016, the Company issued to The Vantage Group Ltd. (“Vantage”), a significant shareholder at that time, a
7% unsecured promissory note in the amount of $10,000 which had an original maturity of six months from the date of issuance.
On August 15, 2016, the Company issued to Vantage a 7% unsecured promissory note in the amount of $16,000 which had an original
maturity of six months from the date of issuance. On October 27, 2016, the Company issued the same shareholder a 7% unsecured
promissory note in the amount of $10,000 which had an original maturity date of six months from the date of issuance. On November
14, 2016, the Company issued the same shareholder a 7% unsecured promissory note in the amount of $80,000 which had an original
maturity date of six months from the date of issuance. On March 31, 2017, the Company issued the same shareholder a 7% unsecured
promissory note in the amount of $7,000 which had an original maturity date of six months from the date of issuance.
On
April 17, 2017 the preceding notes issued to Vantage were amended to be convertible into common stock and to mature on April 18,
2018. The convertible notes had a fixed conversion price of $0.008. The amendments to the notes created a beneficial conversion
feature of $123,000 and amortization of the discount of $123,000 during the year ended August 31, 2018. The Company issued a total
of 10,050,000 shares of common stock to convert $80,000 principal and $400 of accrued interest into common stock and the remaining
$43,000 was exchanged with an additional $2,000 of accrued interest to purchase assets of the Company.
The
changes in notes payable to these related parties consisted of the following during the years ended August 31, 2019 and August
31, 2018.
|
|
August 31,
2019
|
|
|
August 31, 2018
|
|
Notes payable – related party at beginning of period
|
|
$
|
-
|
|
|
$
|
153,000
|
|
Payments on notes payable – related party
|
|
|
-
|
|
|
|
(30,000
|
)
|
Conversion
|
|
|
-
|
|
|
|
(80,000
|
)
|
Exchange for purchase of Company assets
|
|
|
-
|
|
|
|
(43,000
|
)
|
Note payables – related party at end of period
|
|
$
|
-
|
|
|
$
|
-
|
|
4.
CONVERTIBLE DEBENTURE – RELATED PARTY
On April 11, 2017, the Company issued a
$540,000 related party convertible debenture with an original issue discount of $180,000. The note had a 0% interest rate and
a term of two years. In connection with the note, the Company issued the lender an aggregate of 2,700,000 shares of common
stock and 900,000 warrants. The relative fair value of the stock ($157,509) and warrants ($44,981) aggregating $202,490 was
recognized as a discount to the note. Amortization of $184,364 was recognized during the year ended August 31, 2019. The
conversion price of the outstanding balance was the lesser of $3.00 or 40% of the volume weighted average price of the prior
30 days at date of conversion; not to be less than $1.00. In connection with the note the lender was entitled to receive the
greater of 5% of every dollar raised by the Company through financing or every dollar of revenue generated by the Company
through the earlier of the maturity date and repayment of the principal. As of August 31, 2019 and August 31, 2018 the
Company has accrued $0 and $34,015, respectively. On April 22, 2019, the Company entered into an exchange agreement with the
lender. Pursuant to the exchange agreement, the lender exchanged convertible debentures of the Company, including the
convertible debenture in the original principal amounts of $540,000 referred to above and an additional convertible debenture
in the original principal amount of $120,000 described below, an aggregate of $93,565 (including $53,790 pursuant to the
$540,000 debenture and $39,775 under the $120,000 debenture) of accrued amounts as the lender was entitled to receive under
such debentures as the greater of 5% of every dollar raised through financing or every dollar of revenue generated through
the earlier of maturity date and repayment of the principal, and an aggregate of 1,000,000 warrants to purchase shares of
common stock of the Company, for an aggregate of 11,000,000 newly issued shares of common stock of the Company.
|
|
August 31,
2019
|
|
|
August 31,
2018
|
|
Related
Party Convertible debenture
|
|
$
|
540,000
|
|
|
$
|
540,000
|
|
Unamortized
discount
|
|
|
-
|
|
|
|
(184,364
|
)
|
Conversion
to common stock
|
|
|
(540,000
|
)
|
|
|
-
|
|
Related
Party Convertible debenture, net of unamortized discount
|
|
$
|
-
|
|
|
$
|
355,636
|
|
On September 18, 2017, the Company issued
to a related party, an $180,000 convertible debenture with an original issue discount of $60,000. The note had a 0% interest
rate and a term of two years. In connection with the note, the Company issued the lender an aggregate of 900,000 shares of
common stock and 300,000 warrants to purchase common stock. The relative fair value of the stock and warrants aggregating
$68,499 was recognized as a discount to the note. Amortization of $98,847 was recognized during the year ended August 30,
2019. The conversion price of the outstanding balance was the lesser of $3.00 or 40% of the volume weighted average
price of the prior 30 days at date of conversion; not to be less than $1.00. In connection with the debenture the lender was
entitled to receive the greater of 5% of every dollar raised through financing or every dollar of revenue generated through
the earlier of the maturity date or repayment of the principal. As of August 30, 2019 and August 31, 2018 the Company has
accrued $0 and $25,000, respectively. On April 22, 2019, the Company entered into an exchange agreement with the lender.
Pursuant to the exchange agreement, the lender exchanged the convertible debenture of the Company, in the original principal
amount of $180,000, $44,775 of accrued amounts as the lender was entitled to receive under such debenture as the greater of
5% of every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date and
repayment of the principal and 300,000 warrants to purchase shares of common stock of the Company, for an aggregate of
3,000,000 newly issued shares of common stock of the Company.
|
|
August 31,
2019
|
|
|
August 31,
2018
|
|
Related Party Convertible debenture
|
|
$
|
180,000
|
|
|
$
|
180,000
|
|
Unamortized discount
|
|
|
-
|
|
|
|
(98,847
|
)
|
Conversion to common stock
|
|
|
(180,000
|
)
|
|
|
-
|
|
Related Party Convertible debenture, net of unamortized discount
|
|
$
|
-
|
|
|
$
|
81,153
|
|
On December 13, 2017, the Company
issued a $120,000 convertible debenture with an original issue discount of $20,000 to the same lender as the holder of the
$540,000 debenture referred to above. The debenture had a 0% interest rate and a term of one year. In connection with the
debenture, the Company issued the lender an aggregate of 200,000 shares of common stock and 100,000 warrants to purchase
common stock. The relative fair value of the stock and warrants aggregating $32,930 was recognized as a discount to the note.
Amortization of $14,936 was recognized during the year ended August 31, 2019. The conversion price of the outstanding
balance was the lesser of $3.00 or 40% of the volume weighted average price of the prior 30 days at date of conversion; not
to be less than $1.00. In connection with the debenture the lender was entitled to receive the greater of 5% of every dollar
raised through financing or every dollar of revenue generated through the earlier of maturity date and repayment of the
principal. As of August 31, 2019 and August 31, 2018 the Company has accrued $0 and $20,000, respectively. On April 22, 2019,
the Company entered into an exchange agreement with the lender. Pursuant to the exchange agreement, the lender exchanged the
convertible debentures of the Company, consisting of the convertible debenture in the original principal amounts of $540,000
referred to above and the additional convertible debenture in the original principal amount of $120,000, an aggregate of
$93,565 (including $53,790 pursuant to the $540,000 debenture and $39,775 under the $120,000 debenture) of accrued amounts as
the lender was entitled to receive under such debentures as the greater of 5% of every dollar raised through financing or
every dollar of revenue generated through the earlier of maturity date and repayment of the principal, and an aggregate of
1,000,000 warrants to purchase shares of common stock of the Company, for an aggregate of 11,000,000 newly issued shares of
common stock of the Company.
|
|
August 31,
2019
|
|
|
August 31,
2018
|
|
Related Party Convertible debenture
|
|
$
|
120,000
|
|
|
$
|
120,000
|
|
Unamortized discount
|
|
|
-
|
|
|
|
(14,936
|
)
|
Conversion to common stock
|
|
|
(120,000
|
)
|
|
|
-
|
|
Related Party Convertible debenture, net of unamortized discount
|
|
$
|
-
|
|
|
$
|
105,064
|
|
5.
EQUITY
Common
Stock
The Company has authorized capital of 800,000,000
shares of common stock with a par value of $0.001, and 50,000,000 shares of Preferred stock with a par value of $0.001. 1,000 shares
of Preferred stock are designated as Series A Convertible Preferred stock.
On June 15, 2018, the Company issued 500,000 shares of common
stock pursuant to a stock purchase agreement for cash of $50,000.
On August 29, 2018 the Company issued 30,000 shares of common stock for services valued at $44,400.
On September 18, 2017, the Company issued
900,000 shares of common stock in connection with the issuance of a convertible note with a principal amount of $180,000. The relative
fair value of the stock of $51,503 was recognized as a discount to the note that is being amortized to interest expense over the
life of the note.
On September 22, 2017, the company issued
900,000 shares of common stock and 300,000 warrants pursuant to a stock purchase agreement for cash of $60,300.
On November 10, 2017, the Company issued
an aggregate of 1,400,000 shares of common stock to the holder of a related party convertible promissory note, to convert principal
amount of $11,200.
On November 27, 2017, the Company issued
an aggregate of 1,450,000 shares of common stock to the holder of a related party convertible promissory note, to convert principal
amount of $11,600.
On December 28, 2017, the Company issued
an aggregate of 1,550,000 shares of common stock to the holder of a convertible promissory note, dated November 14, 2016 to convert
principal amount of $12,400.
On December 13, 2017, the Company issued
an aggregate of 200,000 shares of common stock with a relative fair value of $27,946 to the holder of a $120,000 convertible debenture
with an original issue discount of $20,000. The debenture has a 0% interest rate and a term of one year.
On March 5, 2018, the Company entered into
a securities purchase agreement with an investor which following such investment was a related party. Pursuant to the purchase
agreement, upon closing on March 7, 2018, the Company issued and sold to the investor, 3,000,000 shares of common stock for an
aggregate purchase price of $300,000. The Company agreed to issue additional shares of common stock to the investor for no additional
consideration, in the event that, during the six month period commencing on the closing date, the Company sold common stock at
a purchase price lower than $0.10, such that the total number of shares of common stock received by the investor under the purchase
agreement (including the additional shares and the initial shares) will be equal to the total purchase price of $300,000 divided
by such lower subsequent financing price. In addition, the Company agreed not to pay cash compensation of over $100,000 to any
officer or director for a period of 12 months from the closing date.
On March 9, 2018, the Company issued an
aggregate of 1,780,000 shares of common stock to the holder of a 7% convertible promissory note, dated November 14, 2016 to convert
principal amount of $14,240.
On March 9, 2018, he Company entered into
and closed an asset purchase agreement with VMI Acquisitions, LLC (“VMI”), pursuant to which the Company sold to VMI
the Company’s proprietary Machine-to-Machine communications solution and certain other intellectual property for a purchase
price of $180,000. $135,000 of the purchase price was paid by members of VMI in cash and had previously been deposited with the
Company. The remaining $45,000 of the purchase price was paid in the form of a reduction in outstanding debt and reimbursements
of expenses owed to a member of VMI. Certain members of VMI were noteholders and/or shareholders of the Company. At the time of
the sale the intellectual property had a book value of $0. As the parties were considered significant shareholders and related
parties, the consideration of $180,000 was recorded as a capital contribution.
On May 15, 2018 the Company issued 500,000
shares of common stock to an investor for a purchase price of $50,000, and on May 29, 2018, the Company issued 1,870,000 shares
of common stock upon conversion of a convertible note in the amount of $14,960. The Company agreed to issue additional shares of
common stock to the investor for no additional consideration, in the event that, during the six month period commencing on the
closing date, the Company sold common stock at a purchase price lower than $0.10, such that the total number of shares of common
stock received by the investor under the purchase agreement (including the additional shares and the initial shares) will be equal
to the total purchase price of $50,000 divided by such lower subsequent financing price. In addition, the Company agreed not to
pay cash compensation over $100,000 to any officer or director for a period of 12 months from the closing date.
On June 11, 2018, the Company issued an
aggregate of 2,000,000 shares of common stock to the holder of a convertible promissory note, dated November 14, 2016 to convert
principal amount and accrued interest of $16,000.
On October 13, 2018 the Company issued
1,000,000 shares of common stock for a sponsorship donation valued at $120,000.
Effective October 30, 2018, Marc Yahr resigned
from all positions with the Company including as President and Chief Executive Officer of the Company, except as a member of the
board of directors and on November 25, 2018 Mr. Yahr resigned as a member of the Company’s board of directors. On November
6, 2018, 16,000,000 shares of common stock were returned to the Company by Mr. Yahr for which the Company paid $1,600 to Marc Yahr.
This forfeiture was in accordance with the terms of Mr. Yahr’s employee share based award and the forfeiture resulted in
a gain of $2,440,768 (net of the $1,600 cash paid) representing a reversal of the previously recognized expense for the unvested
portion of this freighted award.
On October 30, 2018, the Company entered
into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company’s Chief Executive Officer
and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to
the terms of the employment agreement, Ms. Noel’s annual salary is $96,000 and she received a warrant to purchase up to 20,000,000
shares of the Company’s common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant for $2,000
and was issued the 20,000,000 shares on October 31, 2018. The shares received upon the exercise of the warrants are subject to
forfeiture over a service period of four years.
Pursuant to a securities purchase agreement
entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock
at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the
six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares
to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be
equal to $50,000 divided by lower financing price. As of August 31, 2019 the Company was obligated to issue 500,000 shares of common
stock valued at $76,000.
On March 20, 2019 the Company issued 500,000
shares of common stock valued at $32,950 ($0.066 per share) pursuant to a consulting agreement. The term of the agreement is one
year and the Company agreed to pay the consultant $20,000 per month once it receives proceeds of financing transactions of at least
$250,000.
During the year ended August 31, 2019,
the Company sold a total of 15,252,381 shares of common stock for proceeds of $421,250.
On April 22, 2019, the Company entered
into an exchange agreement with a debenture holder. Pursuant to the exchange agreement, the lender exchanged convertible debentures
of the Company, consisting of convertible debentures in the original principal amounts of $540,000 and $120,000, an aggregate
of $93,565 (including $53,790 pursuant to the $540,000 debenture and $39,775 under the $120,000 debenture) of accrued amounts
as the lender was entitled to receive under such debentures as the greater of 5% of every dollar raised through financing or every
dollar of revenue generated through the earlier of maturity date and repayment of the principal, and an aggregate of 1,000,000
warrants to purchase shares of common stock of the Company, for an aggregate of 11,000,000 newly issued shares of common stock
of the Company.
On April 22, 2019, the Company entered into
an exchange agreement with a debenture holder. Pursuant to the exchange agreement, the holder exchanged a convertible debenture
of the Company, in the original principal amount of $180,000, $44,775 of accrued amounts as the lender was entitled to receive
greater of 5% of every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date
and repayment of the principal and 300,000 warrants to purchase shares of common stock of the Company, for an aggregate of 3,000,000
newly issued shares of common stock of the Company.
On May 5, 2019 the Company issued 500,000 shares
of common stock valued at $29,000 ($0.058 per share) pursuant to a consulting agreement. The term of the agreement was six months
and the Company agreed to pay the consultant $2,500 per month. Effective November 11, 2019, this agreement was terminated and the
Company issued an additional 4,500,000 shares of common stock.
Warrants
On September 18, 2017, the Company issued to related
party, an $180,000 convertible debenture with an original issue discount of $60,000. The debenture had a 0% interest rate and a
term of two years. In connection with the debenture, the Company issued the lender an aggregate of 900,000 shares of common stock
and 300,000 warrants to purchase common stock. The relative fair value of the stock and warrants aggregating $68,499 was recognized
as a discount to the note. On April 22, 2019, the Company entered into an exchange agreement with the lender. Pursuant to the exchange
agreement, the lender exchanged the convertible debenture of the Company, in the original principal amount of $180,000, $44,775
of accrued amounts as the lender was entitled to receive under such debenture as the greater of 5% of every dollar raised through
financing or every dollar of revenue generated through the earlier of maturity date and repayment of the principal and 300,000
warrants to purchase shares of common stock of the Company, for an aggregate of 3,000,000 newly issued shares of common stock of
the Company (see Note 4).
On December 13, 2017, the Company issued 100,000
warrants to a lender. The relative fair value of the warrants of $4,984 was recognized as a discount to the debenture. On April
22, 2019, the Company entered into an exchange agreement with the lender. Pursuant to the exchange agreement, the lender exchanged
the convertible debentures of the Company, consisting of the convertible debenture in the original principal amount of $540,000
referred to below and the additional convertible debenture in the original principal amount of $120,000, an aggregate of $93,565
(including $53,790 pursuant to the $540,000 debenture and $39,775 under the $120,000 debenture) of accrued amounts as the lender
was entitled to receive under such debentures as the greater of 5% of every dollar raised through financing or every dollar of
revenue generated through the earlier of maturity date and repayment of the principal, and an aggregate of 1,000,000 warrants to
purchase shares of common stock of the Company, for an aggregate of 11,000,000 newly issued shares of common stock of the Company
(see Note 4).
On April 11, 2017, the Company issued a
$540,000 related party convertible debenture with an original issue discount of $180,000. The note had a 0% interest rate and a
term of two years. In connection with the note, the Company issued the lender an aggregate of 2,700,000 shares of common stock
and 900,000 warrants. During the year ended August 31, 2019, 900,000 warrants were exchanged for common stock (see Note 4).
On January 22, 2018, the Company entered
into a sales representation agreement for a term of six months. Pursuant to the agreement the Company agreed to issue the nonemployee
sales representative warrants to purchase 10,000 shares of common stock per month (an aggregate of 60,000 warrants) with an exercise
price of $0.50, with a term of three years. The warrants shall be exercisable at any time on or after the six (6) month anniversary
of each issuance date, at his election, in whole or in part, by means of a “cashless exercise”. The fair value of this
award was determined to be $58,816 of which $51,635 was recognized during the year ended August 31, 2018. During the year ended
August 31, 2019 the Company recognized a gain of ($30,227) due to a remeasurement of this nonemployee award.
On February 22, 2018, the Company entered
into a consulting agreement for a term of one year. Pursuant to the agreement the Company agreed to issue the nonemployee consultant
warrants to purchase 10,000 shares of common stock per month (an aggregate of 120,000 warrants) with an exercise price of $0.40,
exercisable for cash only for a period of three years commencing six months form the issuance date. The fair value of this award
was determined to be $106,663 of which $65,005 was recognized during the year ended August 31, 2018. During the year ended August
31, 2019 the Company recognized a gain of ($55,935) due to a remeasurement of this nonemployee award.
On March 2, 2018, the Company entered into
a management agreement with Global Corporate Management, LLC. Pursuant to this agreement, the Company agreed to pay $4,000 and
to issue 150,000 common stock purchase warrants with an exercise price of $0.50, exercisable commencing six months after issuance
for a period of 5 years. The fair value of this award was determined to be $3,419,925 of which $1,457,561 was recognized during
the year ended August 31, 2018. During the year ended August 31, 2019 the Company recognized a gain of ($1,332,332) due to a remeasurement
of this nonemployee award. On March 2, 2019 the agreement was terminated.
On March 20, 2018, the Company entered
into a 12 month consulting agreement with Patagonia Global Trading, LLC. Upon execution of this agreement and upon the consultant
signing their first customer, acceptable by the Company, and for services rendered, the Company will immediately issue 50,000 common
stock purchase warrants to purchase common stock at an exercise price of $.30 per share. As of August 31, 2018, Patagonia Global
Trading, LLC, had not signed any customers and had not earned any warrants. The Company agreed to pay a total commission rate of
10% of the gross sale amount to be paid in the form of cash and or warrants to purchase shares of common stock of the Company.
As of August 31, 2019, the agreement has expired.
On April 16, 2018, the Company entered
into a consulting agreement with Dr. David Hellman for marketing and promotion services. The term is 1 year with payment of 50,000
warrants each month to purchase common stock with an exercise price of $0.60. However, if the Consultant generates more than $10,000
in monthly sales, the Warrants will have an exercise price of $.30, and if the Consultant generates more than $20,000 in monthly
sales, the Warrants may be exchanged in “cashless exercise”. Additionally, the Company shall pay 10% of retail sales
and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement. On August 1, 2018 the Company entered into a
new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000 warrants each month to purchase common stock
with an exercise price of $0.60. The warrants may be exercised on a cashless basis. A total of $256,038 warrant expense in relation
to this award was recognized during the year ended August 31, 2018. During the year ended August 31, 2019 the Company recognized
a gain of ($217,402) due to a remeasurement of this nonemployee award.
On May 22, 2017, the Company entered into
an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years,
unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement,
Mr. Yahr received a warrant to purchase up to 20,000,000 shares of the Company’s common stock at an exercise price of $0.0001
per share. The warrants were exercised in full on May 31, 2017; however, the 20,000,000 shares of the Company’s common stock
were not issued to Mr. Yahr until June 10, 2017. The shares received upon the exercise of the warrants were subject to forfeiture
over a service period of three years. The fair value of the award was determined to be $10,998,105 which will be recognized as
compensation expense over the three year service period. Warrant expense under the award for the year ended August 31, 2018
totaled $3,633,532. Effective October 30, 2018, Marc Yahr resigned from all positions with the Company including as President and
Chief Executive Officer of the Company (except as director, which he resigned as on November 25, 2018). Pursuant to the agreement,
Mr. Yahr agreed to return 80% of the warrant shares to the Company if he served as CEO of the Company pursuant to the terms and
conditions of the employment agreement for a period of more than 12 months but less than 18 months. Therefore, 16,000,000 shares
of common stock were forfeited to the Company, and the Company recognized a gain on the forfeited common shares of ($2,440,768)
net of $1,600 paid by the Company.
On October 30, 2018, the Company entered
into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company’s Chief Executive Officer
and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to
the terms of the employment agreement, Ms. Noel’s annual salary is $96,000 and she received a warrant to purchase up to 20,000,000
shares of the Company’s common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant and was issued
the 20,000,000 shares on October 31, 2018. The fair value of this award was determined to be $2,598,138 of which $542,390 was recognized
during the year ended August 31, 2019. Unamortized expense at August 31, 2019 is $2,055,748. The shares received upon the exercise
of the warrants are subject to forfeiture over a service period of four years. The shares will be required to be returned to the
Company as follows and the Company accounts for forfeitures when they occur:
Ms. Noel would have been required to return
80% of the common stock to the Company if she was not serving as Chief Executive Officer of the Company pursuant to the terms and
conditions of her employment agreement as of October 30, 2019 (the first anniversary of the employment agreement);
Ms. Noel shall return 60% of the common
stock to the Company if she is not serving as the Chief Executive Officer of the Company pursuant to the terms and conditions of
the employment agreement as of the second anniversary of the employment agreement (October 30, 2020);
Ms. Noel shall return 40% of the common
stock to the Company if she is not serving as Chief Executive Officer of the Company pursuant to the terms and conditions of the
employment agreement as of the third anniversary of the employment agreement (October 30, 2021);
Ms. Noel shall return 20% of the common
stock to the Company if she is not serving as the Chief Executive Officer of the Company pursuant to the terms and conditions of
the employment agreement as of the fourth anniversary of the employment agreement (October 30, 2022);
The following table summarizes the warrant
activities during the years ended August 31, 2018 and 2019:
|
|
Number of
Warrants
|
|
|
Weighted-
Average
Price Per
Share
|
|
|
|
|
|
|
|
|
Outstanding at August 31, 2017
|
|
|
900,000
|
|
|
$
|
1.00
|
|
Granted
|
|
|
1,930,000
|
|
|
|
0.69
|
|
Cancelled or expired
|
|
|
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
Outstanding at August 31, 2018
|
|
|
2,830,000
|
|
|
$
|
0.79
|
|
Granted
|
|
|
21,800,000
|
|
|
|
0.04
|
|
Canceled or expired
|
|
|
(1,300,000
|
)
|
|
|
1.00
|
|
Exercised / Exchanged
|
|
|
(20,000,000
|
)
|
|
|
0.00
|
|
Outstanding at August 31, 2019
|
|
|
3,330,000
|
|
|
$
|
0.56
|
|
Exercisable at August 31, 2019
|
|
|
2,550,000
|
|
|
$
|
0.52
|
|
Intrinsic value at August 31, 2019
|
|
|
|
|
|
$
|
-
|
|
The
fair value of the warrants was estimated using the Black-Scholes option pricing model and the following range of assumptions:
|
|
Grant Date and Re-measurement Date
|
For the year ended August 31, 2019
|
|
|
Risk-free interest rate at grant date
|
|
1.45% - 2.99%
|
Expected stock price volatility
|
|
330% - 788%
|
Expected dividend payout
|
|
-
|
Expected life in years
|
|
2.5 - 6.0 years
|
|
|
Grant Date and Re-measurement Date
|
For the year ended August 31, 2018
|
|
|
Risk-free interest rate at grant date
|
|
1.52% -2.70%
|
Expected stock price volatility
|
|
183% - 362%
|
Expected dividend payout
|
|
-
|
Expected life in years
|
|
2.5 - 6.5 years
|
OPTIONS
On July 26, 2017 the Company granted a
nonemployee options to purchase 2,200,000 shares of common stock. The options have a three year term. 1,000,000 options were immediately
exercisable on the date of issuance with an exercise price of $0.001 and the remaining 1,200,000 options vest over a period of
three years at an exercise price of $1.00. On July 26, 2017, 1,000,000 options were exercised. During the year ended August 31,
2019 the Company recognized a gain of $(310,119) due to the re-measurement of this non employee award. During the year ended August
31, 2018 the Company recognized an expense of $1,000,820.
|
|
Number of
Options
|
|
|
Weighted-
Average
Price Per
Share
|
|
Outstanding at August 31, 2017
|
|
|
1,200,000
|
|
|
$
|
1.00
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
Canceled or expired
|
|
|
-
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
Outstanding at August 31, 2018
|
|
|
1,200,000
|
|
|
$
|
1.00
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
Canceled or expired
|
|
|
-
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
Outstanding at August 31, 2019
|
|
|
1,200,000
|
|
|
$
|
1.00
|
|
Exercisable at August 31, 2019
|
|
|
1,200,000
|
|
|
$
|
1.00
|
|
Intrinsic value at August 31, 2019
|
|
|
|
|
|
$
|
-
|
|
|
|
Re-measurement Date
|
For the year ended August 31, 2019
|
|
|
Risk-free interest rate at grant date
|
|
1.50% - 2.78%
|
Expected stock price volatility
|
|
207% - 394%
|
Expected dividend payout
|
|
-
|
Expected life in years
|
|
1.0 - 3.0 years
|
6.
RELATED PARTY TRANSACTIONS
On April 11, 2017, the Company issued a $540,000 related
party convertible debenture with an original issue discount of $180,000. On December 13, 2017, the Company issued a $120,000 related
party convertible debenture with an original issue discount of $20,000 to the same lender. On April 22, 2019, the Company entered
into an exchange agreement with the lender. Pursuant to the exchange agreement, the lender exchanged the convertible debentures
of the Company, consisting of the convertible debenture in the original principal amount of $540,000 and the additional convertible
debenture in the original principal amount of $120,000, an aggregate of $93,565 (including $53,790 pursuant to the $540,000 debenture
and $39,775 under the $120,000 debenture) of accrued amounts as the lender was entitled to receive under such debentures as the
greater of 5% of every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date
and repayment of the principal, and an aggregate of 1,000,000 warrants to purchase shares of common stock of the Company, for
an aggregate of 11,000,000 newly issued shares of common stock of the Company (see Note 4).
On August 29, 2017, the Company received $82,750
as a deposit from two persons, including a significant shareholder, toward the purchase price on an agreement that was being negotiated
with VMI Acquisitions, LLC for purchase of certain of the Company’s assets as well as the payment of $7,500 of expenses
on behalf of the Company. $45,000 of this amount was paid in the form of a reduction in outstanding debt and reimbursements of
expenses owed to a member of VMI. Certain members of VMI were noteholders and/or shareholders of the Company and related parties.
The agreement was completed and closed on March 9, 2018. As the parties were considered significant shareholders the consideration
of $180,000 was recorded as a capital contribution. At the time of the sale the intellectual property had a book value of $0.
On September 18, 2017, the Company issued to a related
party, an $180,000 convertible debenture with an original issue discount of $60,000. On April 22, 2019, the Company entered into
an exchange agreement with the lender. Pursuant to the exchange agreement, the lender exchanged the convertible debenture of the
Company, in the original principal amount of $180,000, $44,775 of accrued amounts as the lender was entitled to receive under
such debenture as the greater of 5% of every dollar raised through financing or every dollar of revenue generated through the
earlier of maturity date and repayment of the principal and 300,000 warrants to purchase shares of common stock of the Company,
for an aggregate of 3,000,000 newly issued shares of common stock of the Company (see Note 4).
On August 29, 2017, the Company received
$45,000 as a deposit from a significant shareholder toward the purchase price on an agreement that was being negotiated with VMI
Acquisitions, LLC for purchase of certain of the Company’s assets.
During the year ended August 31, 2018 sales
to a customer, who is the spouse of one of the Company’s significant shareholders, amounted to $3,975.
7.
COMMITMENTS AND CONTINGENCIES
On
January 22, 2018, the Company entered into a sales representation agreement to manage and solicit orders in a set territory, the
United States, with an initial term of six months. The sales representative shall be compensated 6% of the net sales and three
year warrants monthly to purchase 10,000 shares of common stock at an exercise price of $0.50. Warrants may be exercised after
six month anniversary of issuance date. As of August 31, 2019 the agreement has expired.
On
February 1, 2018 the Company entered into a consulting agreement with Optimal Setup LLC for a term of one year to advise the Company
on search engine optimization and digital marketing. Optimal Setup LLC shall receive monthly for services performed $2,500 and
10,000 warrants for common stock exercisable for cash price of $0.40. Warrants may be exercised after six month anniversary date.
The warrants were granted on February 22, 2018. As of August 31, 2019, the agreement has expired.
On
March 2, 2018 the Company entered into a two year management agreement with Global Corporate Management, LLC (“GCM”).
Pursuant to this agreement, the Company agreed to pay $4,000 and to issue 150,000 common stock purchase warrants (exercise price
of $0.50, 5 year term, exercisable 6 months after issuance). The Company shall pay to GCM a commission equal to 10% of all
sales every month. The commission will be paid only for the sales which have closed and cash has been paid to the Company. As
of August 31, 2019 GCM has not earned any commissions. On March 2, 2019, the agreement was terminated.
On
March 20, 2018 the Company entered into a consulting agreement with Patagonia Global Trading, LLC. Upon execution of this agreement
and upon the consultant signing their first customer, acceptable by the Company, and for services rendered, the Company agreed
to issue 50,000 common stock purchase warrants to purchase common stock at an exercise price of $0.30 per share. As of May 31,
2019, Patagonia Global Trading, LLC, had not signed any customers and had not earned any warrants. The Company agreed to pay a
total commission rate of 10% of the gross sale amount to be paid in the form of cash or warrants to purchase shares of common
stock of the Company at a purchase price of $0.30 per share, exercisable 6 months after issuance. The commission will be paid
on net sales from protected accounts and the consultant will be issued warrants on net invoices that are paid in full and money
is received. As of August 31, 2019 the agreement has expired.
On
April 16, 2018 the Company entered into a consulting agreement with Dr. David Hellman for marketing and promotion services. The
term is 1 year with payment of 50,000 warrants to purchase common stock with an exercise price of $0.60. However, if the consultant
generates more than $10,000 in monthly sales, the warrants will have an exercise price of $0.30, and if the consultant generates
more than $20,000 in monthly sales, the warrants may be exchanged in “cashless exercise”. Additionally, the Company
agreed to pay to the consultant 10% of retail sales and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement.
On August 1, 2018 the Company entered into a new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000
warrants to purchase common stock with an exercise price of $0.60. The warrants may be exercised on a cashless basis. (See note
5).
In May 2018 the Company entered into an
agreement with Seidman Food Brokerage Inc., pursuant to which the Company appointed Seidman Food Brokerage, Inc. as its non-exclusive
regional sales and marketing representative for the company’s product line for 12 months. The broker will be paid a monthly
commission equal to the greater of (1) 5% of collected sales for all invoices generated for CBD products available from their product
line for human consumption for a particular month or (2) solely with respect to the first six months of the term of the agreement.
As of August 31, 2019, Seidman Food Brokerage, Inc. has not earned any commissions and the agreement has expired.
Pursuant to a securities purchase agreement
dated March 5, 2018, in the event that, in the six month period commencing on the closing date of such purchase agreement, the
Company were to sell common stock at a price lower than $0.10 per share (or common stock equivalents with a conversion or exercise
price lower than $0.10 per share (each as adjusted for stock splits, stock dividends, and similar transactions, the “Subsequent
Financing Price”), the Company was required to promptly issue additional shares of common stock to the purchaser for no additional
consideration, such that the total number of shares of common stock received by the purchaser under the Agreement would be equal
to the total purchase price of $300,000 divided by such lower subsequent financing price. As of August 31, 2019, this agreement
was no longer effective and no additional amounts due to the holder.
Pursuant to a securities purchase agreement
dated March 21, 2018, in the event that, in the six month period commencing on the closing date of such purchase agreement, the
Company were to sell common stock at a price lower than $0.10 per share (or common stock equivalents with a conversion or exercise
price lower than $0.10 per share (each as adjusted for stock splits, stock dividends, and similar transactions), the Company was
required to promptly issue additional shares of common stock to the purchaser for no additional consideration, such that the total
number of shares of common stock received by the purchaser under the Agreement would be equal to the total purchase price of $50,000
divided by such lower subsequent financing price. As of August 31, 2019, this agreement was no longer effective and no additional
amounts due to the holder.
Pursuant to a securities purchase agreement
entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock
at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the
six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares
to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be
equal to $50,000 divided by lower financing price. As of August 31, 2019 the Company was obligated to issue 500,000 shares of common
stock valued at $76,000 which is included in the common stock payable in the accompanying balance sheet.
On March 20, 2019 the Company issued 500,000
shares of common stock valued at $32,950 ($0.066 per share) pursuant to a consulting agreement. The term of the agreement was six
months and the Company agreed to pay the consultant $20,000 per month once it receives proceeds of financing transactions of at
least $250,000.
On May 5, 2019 the Company issued 500,000 shares
of common stock valued at $29,000 ($0.058 per share) pursuant to a consulting agreement. The term of the agreement was six months
and the Company agreed to pay the consultant $2,500 per month. Effective November 11, 2019, this agreement was terminated and the
Company issued an additional 4,500,000 shares of common stock.
On July 19, 2019 the Company entered into
a non-binding preliminary term sheet with Cannasaver Corp. (“Cannasaver”). The term sheet contemplates that the Company
will acquire Cannasaver for aggregate consideration of $25,000,000, 80% of which will be in the form of common stock of the Company,
and the remaining 20% of which will be in cash, it being recognized that the Company will need to raise such funds from investors.
The completion of this acquisition will be subject to entering into definitive agreements and the satisfaction of customary closing
conditions, and there is no assurance such transaction will be completed. Cannasaver is partially owned by Lyle Hauser, who is
a former significant stockholder of the Company and is an adviser to the Company. As of the date of this report the transaction
has not been consummated.
8.
INCOME TAXES
On
December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act (the “TCJA”) that significantly reforms
the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). The TCJA, among other things, contains
significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a
flat rate of 21%, effective as of January 1, 2018; limitation of the tax deduction for interest expense; limitation of the deduction
for net operating losses to 80% of current year taxable income and elimination of net operating loss carrybacks, in each case,
for losses arising in taxable years beginning after December 31, 2017 (though any such tax losses may be carried forward indefinitely);
modifying or repealing many business deductions and credits, including reducing the business tax credit for certain clinical testing
expenses incurred in the testing of certain drugs for rare diseases or conditions generally referred to as “orphan drugs”;
and repeal of the federal Alternative Minimum Tax (“AMT”).
The
staff of the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 to address the application of GAAP in
situations when a registrant does not have the necessary information available, prepared or analyzed (including computations)
in reasonable detail to complete the accounting for certain income tax effects of the TCJA. In connection with the initial analysis
of the impact of the TCJA, the Company remeasured its deferred tax assets and liabilities based on the rates at which they are
expected to reverse in the future, which is generally 21%. The remeasurement of the Company’s deferred tax assets and liabilities
was offset by a change in the valuation allowance.
FASB
ASC 740, Income Taxes, requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight
of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration
of all the evidence, both positive and negative, management has determined that a full valuation allowance of $842,165 and $597,359
against its net deferred taxes is necessary as of August 31, 2019 and 2018, respectively.
At August 31, 2019 and August 31, 2018,
respectively, the Company had approximately $3,156,000 and $2,844,000, respectively, of U.S. net operating loss carryforwards remaining,
which expire beginning in 2026 and $655,000 that can be carried forward indefinitely.
As
a result of certain ownership changes, the Company may be subject to an annual limitation on the utilization of its U.S. net operating
loss carryforwards pursuant to Section 382 of the Internal Revenue Code. A study to determine the effect, if any, of this
change, has not been undertaken.
Tax
returns for the years ended August 31, 2019, 2018, 2017, 2016, and 2015 are subject to examination by the Internal Revenue
Service.
A
reconciliation of the Company’s income taxes to amounts calculated at the federal statutory rate is as follows for the years
ended August 31:
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
Federal and state statutory
taxes
|
|
|
(25.00
|
)%
|
|
|
(35.00
|
)%
|
Change in tax rate estimate
|
|
|
-
|
%
|
|
|
14.00
|
%
|
Permanent differences
|
|
|
20.00
|
%
|
|
|
-
|
|
Change in valuation
allowance
|
|
|
5.00
|
%
|
|
|
21.00
|
%
|
|
|
|
-
|
%
|
|
|
-
|
%
|
The
valuation allowance for deferred tax assets as of August 31, 2019 and 2018 was $842,165 and $597,359 respectively. In
assessing the recovery of the deferred tax assets, management considers whether it is more likely than not that some portion or
all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation
of future taxable income in the periods in which those temporary differences become deductible. Management considers
the scheduled reversals of future deferred tax liabilities, projected future taxable income, and tax planning strategies in making
this assessment. As a result, management determined it was more likely than not the deferred tax assets would not be
realized as of August 31, 2019 and 2018 and recorded a full valuation allowance.
Components
of net deferred tax assets, including a valuation allowance, are as follows at August 31:
|
|
2019
|
|
|
2018
|
|
Deferred tax assets:
|
|
|
|
|
|
|
Inventory impairment
|
|
|
13,264
|
|
|
|
-
|
|
Net operating loss
|
|
|
828,901
|
|
|
|
597,359
|
|
Valuation allowance
|
|
|
(842,165
|
)
|
|
|
(597,359
|
)
|
Total deferred tax assets
|
|
$
|
-
|
|
|
$
|
-
|
|
A
reconciliation of the expected income tax benefit at the U.S. Federal income tax rate to the income tax benefit actually recognized
for the years ended August 31, 2019 and 2018 is set forth below:
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
Net (loss) / income
|
|
|
654,094
|
|
|
|
(2,663,345
|
)
|
Non-deductible expenses and other
|
|
|
(833,419
|
)
|
|
|
1,441,043
|
|
Effect due to decrease in tax rates
|
|
|
-
|
|
|
|
1,359,234
|
|
Change in valuation allowance
|
|
|
179,325
|
|
|
|
(136,932
|
)
|
Benefit from income taxes
|
|
$
|
-
|
|
|
$
|
-
|
|
As
a result of certain ownership changes, the Company may be subject to an annual limitation on the utilization of its U.S. net operating
loss carryforwards pursuant to Section 382 of the Internal Revenue Code. A study to determine the effect, if any, of this
change, has not been undertaken.
9. MAJOR CUSTOMERS
There are concentrations of credit risk
with respect to accounts receivables due to the amounts owed by one customer at August 31, 2019 whose balance represented approximately
28%, of total accounts receivables. During the year ended August 31, 2019 no individual customer amounted to over 10% of total
sales. During the year ended August 31, 2018 sales to one customer, who is the spouse of one of the Company’s significant
shareholders, amounted to 24% of sales. The loss of business from one or a combination of the Company’s significant customers,
or an unexpected deterioration in their financial condition, could adversely affect the Company’s operations.
10.
SUBSEQUENT EVENTS
On
October 3, 2019, the Company entered into a letter agreement with Niquana Noel, the Company’s chief executive officer. Pursuant
to the agreement, Ms. Noel exchanged $24,000 in accrued but unpaid compensation owed to her by the Company for one share of newly
created Series B Preferred Stock of the Company.
In
connection with the letter agreement, on October 3, 2019, the Company filed a Certificate of Designation of Series B Preferred
Stock with the Secretary of State of Nevada. Pursuant to the Certificate of Designation, the Company designated one share of its
preferred stock as Series B Preferred Stock. The Series B Preferred Stock has a stated value of $24,000 and entitles the holder
to 51% of the total voting power of the Company’s stockholders. The Company may, in its sole discretion, redeem the Series
B Preferred Stock at any time for a redemption price equal to the stated value. The Series B Preferred does not provide the holder
with any dividend rights or any liquidation rights, and is not convertible to common stock.
On October 14, 2019, the Company entered into
and closed a securities purchase agreement with an accredited investor pursuant to which the Company issued and sold to the investor
20,833,333 shares of common stock for a purchase price of $125,000.
In November 2019, 3,000,000 shares of common
stock were returned to the Company for cancellation and the Company paid $27,500 in connection with a settlement agreement.
On November 6, 2019, the Company entered
into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to
the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal
amount of $200,000, for a purchase price of $100,000. The Company also issued to the investor 4,900,000 shares of common stock.
As amended, the debenture matures on August 1, 2020 and is convertible into shares of common stock of the Company at a conversion
price of $0.006, provided that, if the Company fails to repay the debenture upon maturity, the conversion price will be reduced
to $0.001 (subject to adjustment for stock splits, stock dividends and similar transactions) and the debenture will bear interest
at the rate of 9% per year. The debenture may not be converted to common stock to the extent such conversion would result in the
holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The Company’s obligation to repay
the debenture upon maturity is secured by a security interest in the Company’s URLs pursuant to a security agreement between
the Company and the investor.
Effective November 11, 2019, the Company
issued 4,500,000 shares of common stock pursuant to a consulting agreement (see Note 5).